Cargando…
A Case of Diffuse Astrocytoma with 32-year Survival after Boron Neutron Capture Therapy
A 39-year-old man had received boron neutron capture therapy (BNCT) for a grade II astrocytoma (compatible with diffuse astrocytoma, not otherwise specified in the WHO 2016 criteria). He returned to his previous work after surgery, but, 7 years later, he suddenly developed seizures, and his health c...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538456/ https://www.ncbi.nlm.nih.gov/pubmed/33062571 http://dx.doi.org/10.2176/nmccrj.cr.2019-0228 |